Tudor Investment Corp’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-103,373
| Closed | -$1.62M | – | 1549 |
|
|
2025
Q1 | $1.62M | Buy |
103,373
+39,039
| +61% | +$611K | 0.01% | 878 |
|
|
2024
Q4 | $896K | Buy |
64,334
+43,370
| +207% | +$604K | ﹤0.01% | 1041 |
|
|
2024
Q3 | $195K | Buy |
+20,964
| New | +$195K | ﹤0.01% | 1415 |
|
|
2024
Q2 | – | Sell |
-204,779
| Closed | -$2.03M | – | 1494 |
|
|
2024
Q1 | $2.03M | Buy |
+204,779
| New | +$2.03M | 0.01% | 674 |
|
|
2023
Q4 | – | Sell |
-45,461
| Closed | -$241K | – | 1465 |
|
|
2023
Q3 | $241K | Buy |
+45,461
| New | +$241K | ﹤0.01% | 1290 |
|
|
2023
Q2 | – | Sell |
-30,306
| Closed | -$333K | – | 1524 |
|
|
2023
Q1 | $333K | Buy |
+30,306
| New | +$333K | 0.01% | 1247 |
|
|
2022
Q4 | – | Sell |
-18,349
| Closed | -$351K | – | 1539 |
|
|
2022
Q3 | $351K | Buy |
+18,349
| New | +$351K | 0.01% | 1235 |
|